Company intelligence / Profile preview

CapHorn Invest

Paris, France

Ownership: Private
Employees: ~51
Development stage: Other

Overview

CapHorn Invest is a venture capital firm that specializes in early-stage and growth investments within B2B digital companies. Their investment focus includes healthcare (medical devices, digital health), environmental transition, and digital transformation, with typical ticket sizes ranging from 300K to 20M€. They have invested in biotech companies such as Phagos (AI-driven phage therapies) and have been acquired by Anaxago.

Industry: Investors

Beyond the preview

Go deeper on CapHorn Invest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CapHorn Invest.

Explore the full profile